COVID-19 vaccine in the Kingdom of Saudi Arabia: A true operation warp speed
As of January 2021, 1 year has passed since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first discovered, which is the cause of the coronavirus disease-2019 (COVID-19) pandemic that has infected almost 100 million people worldwide and caused almost two million deaths. In 202...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Journal of Nature and Science of Medicine |
| Subjects: | |
| Online Access: | http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2021;volume=4;issue=2;spage=92;epage=98;aulast=Barry |
| Summary: | As of January 2021, 1 year has passed since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first discovered, which is the cause of the coronavirus disease-2019 (COVID-19) pandemic that has infected almost 100 million people worldwide and caused almost two million deaths. In 2020, in an unprecedented scientific achievement, several vaccines were developed, underwent clinical trials, and were distributed worldwide. This was made possible, in part, by Operation Warp Speed, which promoted mass production of multiple vaccines through different technological platforms, relying on preliminary evidence to allow faster distribution as soon as clinical trials confirmed one or more of those vaccines to be safe and effective. The Kingdom of Saudi Arabia (KSA) was one of the very first countries in the world to grant emergency use authorization to the BNT162b2 vaccine, a new type of modified RNA vaccine developed by Pfizer-BioNTech. Here, we review various COVID-19 vaccines and the success of the vaccine rollout in KSA. |
|---|---|
| ISSN: | 2589-627X 2589-6288 |